{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T14:26:23Z","timestamp":1771079183729,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012352","name":"Universit\u00e0 degli Studi di Milano","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012352","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In the last 10\u00a0years, the use of dual antiplatelet therapy (DAPT) in the neurological ambit has been explored in patients with non-cardioembolic ischemic stroke, transient ischemic attack (TIA), and intracranial atherosclerotic disease. Two clinical trials (CHANCE and POINT) showed that in patients with minor non-cardioembolic ischemic stroke or high-risk TIA, the addition of clopidogrel to aspirin reduces the risk of stroke recurrence. Another trial (THALES) evaluated the association of ticagrelor and aspirin in mild-to-moderate non-cardioembolic ischemic stroke or high-risk TIA, showing a reduced risk of subsequent stroke compared to aspirin alone. Finally, the use of DAPT has been assessed in the treatment of stroke associated with atherosclerotic intracranial stenosis in the SAMMPRIS trial, showing a favorable profile compared to percutaneous angioplasty and stenting. The aim of this article is, after a review the major trials evaluating DAPT in patients with ischemic cerebrovascular events and the ways they have been implemented in Italian, European, and USA guidelines, to provide a practical algorithm to help clinicians in their everyday clinical practice and to outline possible caveats in the practical implementation of guidelines. Possible limitations and gaps in knowledge regarding specific conditions (e.g., the use of DAPT after acute phase therapies) are also underlined.<\/jats:p>","DOI":"10.1007\/s10072-022-06395-z","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T09:03:35Z","timestamp":1663405415000},"page":"37-43","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The use of dual antiplatelet therapy for ischemic cerebrovascular events"],"prefix":"10.1007","volume":"44","author":[{"given":"Francesco","family":"Mele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Gendarini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7357-8530","authenticated-orcid":false,"given":"Leonardo","family":"Pantoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,9,17]]},"reference":[{"issue":"17","key":"6395_CR1","doi-asserted-by":"publisher","first-page":"E1371","DOI":"10.4244\/EIJ-D-21-00904","volume":"17","author":"DJ Angiolillo","year":"2022","unstructured":"Angiolillo DJ, Galli M, Collet JP, Kastrati A, O\u2019Donoghue ML (2022) Antiplatelet therapy after percutaneous coronary intervention. EuroIntervention 17(17):E1371\u2013E1396. https:\/\/doi.org\/10.4244\/EIJ-D-21-00904","journal-title":"EuroIntervention"},{"issue":"3","key":"6395_CR2","doi-asserted-by":"publisher","first-page":"E18","DOI":"10.1161\/CIR.0000000000001038","volume":"145","author":"JS Lawton","year":"2022","unstructured":"Lawton JS, Tamis-Holland JE, Bangalore S et al (2022) 2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 145(3):E18\u2013E114. https:\/\/doi.org\/10.1161\/CIR.0000000000001038","journal-title":"Circulation"},{"issue":"10","key":"6395_CR3","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","volume":"68","author":"GN Levine","year":"2016","unstructured":"Levine GN, Bates ER, Bittl JA et al (2016) 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 68(10):1082\u20131115. https:\/\/doi.org\/10.1016\/j.jacc.2016.03.513","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"6395_CR4","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A et al (2019) 2018 ESC\/EACTS guidelines on myocardial revascularization. Eur Heart J 40(2):87\u2013165. https:\/\/doi.org\/10.1093\/eurheartj\/ehy394","journal-title":"Eur Heart J"},{"issue":"34","key":"6395_CR5","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","volume":"42","author":"FLJ Visseren","year":"2021","unstructured":"Visseren FLJ, MacH F, Smulders YM et al (2021) 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 42(34):3227\u20133337. https:\/\/doi.org\/10.1093\/eurheartj\/ehab484","journal-title":"Eur Heart J"},{"issue":"7435","key":"6395_CR6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1136\/bmj.37991.6352664","volume":"328","author":"AJ Coull","year":"2004","unstructured":"Coull AJ, Lovett JK, Rothwell PM (2004) Oxford Vascular Study Population based study of early risk of stroke after transient ischaemic attack or minor stroke implications for public education and organisation of services. BMJ 328(7435):326. https:\/\/doi.org\/10.1136\/bmj.37991.6352664","journal-title":"BMJ"},{"issue":"12","key":"6395_CR7","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S1474-4422(07)70274-0","volume":"6","author":"MF Giles","year":"2007","unstructured":"Giles MF, Rothwell PM (2007) Risk of stroke early after transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 6(12):1063\u20131072. https:\/\/doi.org\/10.1016\/S1474-4422(07)70274-0","journal-title":"Lancet Neurol"},{"issue":"9065","key":"6395_CR8","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/S0140-6736(97)04011-7","volume":"349","author":"The International Stroke Trial (IST)","year":"1997","unstructured":"The International Stroke Trial (IST) (1997) a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke International Stroke Trial Collaborative Group. Lancet 349(9065):1569\u201381","journal-title":"Lancet"},{"issue":"9066","key":"6395_CR9","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0140-6736(97)04010-5","volume":"349","author":"CAST","year":"1997","unstructured":"CAST (1997) randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke CAST (Chinese Acute Stroke Trial) Collaborative Group. Lancet 349(9066):1641\u20139","journal-title":"Lancet"},{"key":"6395_CR10","doi-asserted-by":"publisher","unstructured":"Sandercock PA, Counsell C, Gubitz GJ, Tseng MC (2008) Antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev 16(3):CD000029. https:\/\/doi.org\/10.1002\/14651858.CD000029.pub2. Update in: Cochrane Database Syst Rev. 2014;3:CD000029","DOI":"10.1002\/14651858.CD000029.pub2"},{"issue":"11","key":"6395_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/S1474-4422(07)70250-8","volume":"6","author":"J Kennedy","year":"2007","unstructured":"Kennedy J, Hill MD, Ryckborst KJ, Eliasziw M, Demchuk AM, Buchan AM (2007) Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol 6(11):961\u2013969. https:\/\/doi.org\/10.1016\/S1474-4422(07)70250-8","journal-title":"Lancet Neurol"},{"issue":"1","key":"6395_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1215340","volume":"369","author":"Y Wang","year":"2013","unstructured":"Wang Y, Wang Y, Zhao X et al (2013) Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. NEJM Org N Engl J Med 369(1):11\u201319. https:\/\/doi.org\/10.1056\/NEJMoa1215340","journal-title":"NEJM Org N Engl J Med"},{"issue":"3","key":"6395_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/nejmoa1800410","volume":"379","author":"SC Johnston","year":"2018","unstructured":"Johnston SC, Easton JD, Farrant M et al (2018) Clopidogrel and aspirin in acute ischemic stroke and high-risk TIA. N Engl J Med 379(3):215\u2013225. https:\/\/doi.org\/10.1056\/nejmoa1800410","journal-title":"N Engl J Med"},{"issue":"3","key":"6395_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/nejmoa1916870","volume":"383","author":"SC Johnston","year":"2020","unstructured":"Johnston SC, Amarenco P, Denison H et al (2020) Ticagrelor and aspirin or aspirin alone in acute ischemic stroke or TIA. N Engl J Med 383(3):207\u2013217. https:\/\/doi.org\/10.1056\/nejmoa1916870","journal-title":"N Engl J Med"},{"issue":"4","key":"6395_CR15","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jstrokecerebrovasdis.2011.05.001","volume":"20","author":"MI Chimowitz","year":"2011","unstructured":"Chimowitz MI, Lynn MJ, Turan TN et al (2011) Design of the Stenting and Aggressive Medical Management for Preventing Recurrent stroke in Intracranial Stenosis trial. J Stroke Cerebrovasc Dis 20(4):357\u2013368. https:\/\/doi.org\/10.1016\/j.jstrokecerebrovasdis.2011.05.001","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"6395_CR16","doi-asserted-by":"publisher","unstructured":"Gutierrez J, Turan TN, Hoh BL, Chimowitz MI (2022) Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment. Lancet Neurol 21(4):355\u2013368. https:\/\/doi.org\/10.1016\/S1474-4422(21)00376-8. Erratum in: Lancet Neurol. 2022.","DOI":"10.1016\/S1474-4422(21)00376-8"},{"key":"6395_CR17","unstructured":"SPREAD (Stroke Prevention and Educational Awareness Diffusion) (2017) Italian guidelines For stroke prevention and management. 8th ed. ISO.\u00a0http:\/\/iso-spread.it. Accessed 15 June 2022"},{"key":"6395_CR18","doi-asserted-by":"publisher","unstructured":"Dawson J, Merwick \u00c1, Webb A, Dennis M, Ferrari J, Fonseca AC; European Stroke Organisation (2021) European Stroke Organisation expedited recommendation for the use of short-term dual antiplatelet therapy early after minor stroke and high-risk TIA. Eur Stroke J 6(2):CLXXXVII-CXCI. https:\/\/doi.org\/10.1177\/23969873211000877","DOI":"10.1177\/23969873211000877"},{"key":"6395_CR19","doi-asserted-by":"publisher","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC Jr, Turan TN, Williams LS (2021) Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association. Stroke 52(7):e364-e467. https:\/\/doi.org\/10.1161\/STR.0000000000000375. Epub 2021 May 24. Erratum in: Stroke. 2021 Jul;52(7):e483-e484. PMID: 34024117","DOI":"10.1161\/STR.0000000000000375"},{"key":"6395_CR20","doi-asserted-by":"publisher","unstructured":"Psychogios M., Brehm A., L\u00f3pez-Cancio E., De Marchis GM, Meseguer E, Katsanos AH, Kremer C, Sporns P, Zedde M, Kobayashi A, Caroff J, Bos D, L\u00e9meret S, Lal A, Arenillas JF European Stroke Organisation guidelines on treatment of patients with intracranial atherosclerotic disease. Eur Stroke J I\u2013XXXIX. https:\/\/doi.org\/10.1177\/23969873221099715","DOI":"10.1177\/23969873221099715"},{"issue":"24 Pt 2","key":"6395_CR21","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1212\/01.wnl.0000304346.14354.0b","volume":"70","author":"S Sato","year":"2008","unstructured":"Sato S, Toyoda K, Uehara T et al (2008) Baseline NIH Stroke Scale Score predicting outcome in anterior and posterior circulation strokes. Neurology 70(24 Pt 2):2371\u20132377. https:\/\/doi.org\/10.1212\/01.wnl.0000304346.14354.0b","journal-title":"Neurology"},{"issue":"4","key":"6395_CR22","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1159\/000358869","volume":"37","author":"V Inoa","year":"2014","unstructured":"Inoa V, Aron AW, Staff I, Fortunato G, Sansing LH (2014) Lower NIH stroke scale scores are required to accurately predict a good prognosis in posterior circulation stroke. Cerebrovasc Dis 37(4):251\u2013255. https:\/\/doi.org\/10.1159\/000358869","journal-title":"Cerebrovasc Dis"},{"issue":"1","key":"6395_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/STROKEAHA.116.013432","volume":"48","author":"JT Kim","year":"2017","unstructured":"Kim JT, Park MS, Choi KH et al (2017) Clinical outcomes of posterior versus anterior circulation infarction with low national institutes of health stroke scale scores. Stroke 48(1):55\u201362. https:\/\/doi.org\/10.1161\/STROKEAHA.116.013432","journal-title":"Stroke"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06395-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-022-06395-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-022-06395-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T05:02:08Z","timestamp":1672981328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-022-06395-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,17]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["6395"],"URL":"https:\/\/doi.org\/10.1007\/s10072-022-06395-z","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,17]]},"assertion":[{"value":"5 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not require patients\u2019 involvement. No ethical approval or acquisition of informed consent were pursued.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Informed consent"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}